Header Logo

Connection

FRANCESCA POLVERINO to Pulmonary Disease, Chronic Obstructive

Back to Details
This is a "connection" page, showing publications FRANCESCA POLVERINO has written about Pulmonary Disease, Chronic Obstructive.
FRANCESCA POLVERINO
Connection Strength
19.364
Pulmonary Disease, Chronic Obstructive
  1. Access to Treatment for Chronic Obstructive Pulmonary Disease in the Americas: A Call for Action. A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and the American Thoracic Society. Ann Am Thorac Soc. 2024 Nov; 21(11):1463-1470.
    View in: PubMed
    Score: 0.573
  2. Type 2 airway inflammation in COPD. Eur Respir J. 2024 May; 63(5).
    View in: PubMed
    Score: 0.556
  3. Clearing the Air: Innovations in Imaging for Early Detection and Management of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 04 15; 209(8):1042-1043.
    View in: PubMed
    Score: 0.551
  4. Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 01 01; 209(1):48-58.
    View in: PubMed
    Score: 0.540
  5. From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator. Eur Respir J. 2023 09; 62(3).
    View in: PubMed
    Score: 0.531
  6. Blunted adaptive immune responses and acute exacerbations of COPD: breaking the code. Eur Respir J. 2023 08; 62(2).
    View in: PubMed
    Score: 0.525
  7. Leveraging Omics to Predict Chronic Obstructive Pulmonary Disease Exacerbations: The "Immunome". Am J Respir Crit Care Med. 2023 08 01; 208(3):220-222.
    View in: PubMed
    Score: 0.525
  8. Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link? Am J Respir Cell Mol Biol. 2023 05; 68(5):482-484.
    View in: PubMed
    Score: 0.516
  9. Lung volume reduction in COPD: scope or surgery. Eur Respir J. 2023 04; 61(4).
    View in: PubMed
    Score: 0.516
  10. Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer. Sci Rep. 2022 12 27; 12(1):22402.
    View in: PubMed
    Score: 0.504
  11. Challenges in the Pharmacotherapy of COPD Subtypes. Arch Bronconeumol. 2023 05; 59(5):284-287.
    View in: PubMed
    Score: 0.500
  12. Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials. Am J Respir Crit Care Med. 2022 10 15; 206(8):1051-1052.
    View in: PubMed
    Score: 0.497
  13. The lower respiratory tract: the hot spot for chronic fixed airflow limitation. Eur Respir J. 2022 10; 60(4).
    View in: PubMed
    Score: 0.496
  14. The low flyers: persistent airflow limitation in young adults. Lancet Respir Med. 2022 09; 10(9):819-822.
    View in: PubMed
    Score: 0.488
  15. Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection. Cells. 2022 06 07; 11(12).
    View in: PubMed
    Score: 0.485
  16. Adaptive immune responses and protein homeostasis in COPD: the immunoproteasome. Eur Respir J. 2022 03; 59(3).
    View in: PubMed
    Score: 0.476
  17. Tweaking lung inflammation in COPD: the "mirky" ways of miRNAs. Am J Physiol Lung Cell Mol Physiol. 2021 12 01; 321(6):L1089-L1090.
    View in: PubMed
    Score: 0.465
  18. Asthma and Chronic Obstructive Pulmonary Disease: Just Old Friends or Relatives? Am J Respir Crit Care Med. 2021 10 01; 204(7):870-871.
    View in: PubMed
    Score: 0.462
  19. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. Am J Respir Crit Care Med. 2021 09 15; 204(6):651-666.
    View in: PubMed
    Score: 0.461
  20. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med. 2021 Aug 23; 21(1):275.
    View in: PubMed
    Score: 0.459
  21. Smoking Pattern in Men and Women: A Possible Contributor to Sex Differences in Smoke-related Lung Diseases. Am J Respir Crit Care Med. 2020 10 01; 202(7):1048-1051.
    View in: PubMed
    Score: 0.431
  22. Small airways and early origins of COPD: pathobiological and epidemiological considerations. Eur Respir J. 2020 03; 55(3).
    View in: PubMed
    Score: 0.415
  23. Lung MRI as a Potential Complementary Diagnostic Tool for Early COPD. Am J Med. 2020 06; 133(6):757-760.
    View in: PubMed
    Score: 0.411
  24. B Cell-Adaptive Immune Profile in Emphysema-Predominant Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2019 12 01; 200(11):1434-1439.
    View in: PubMed
    Score: 0.407
  25. COPD: To Be or Not to Be, That is the Question. Am J Med. 2019 11; 132(11):1271-1278.
    View in: PubMed
    Score: 0.393
  26. Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners? Am J Respir Crit Care Med. 2019 05 01; 199(9):1170-1171.
    View in: PubMed
    Score: 0.391
  27. Prognostic Validation Using GesEPOC 2017 Severity Criteria. Arch Bronconeumol (Engl Ed). 2019 Aug; 55(8):409-413.
    View in: PubMed
    Score: 0.384
  28. What is early COPD and why is it important? Eur Respir J. 2018 12; 52(6).
    View in: PubMed
    Score: 0.380
  29. A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 11 15; 198(10):1254-1267.
    View in: PubMed
    Score: 0.379
  30. The Challenge of Controlling the COPD Epidemic: Unmet Needs. Am J Med. 2018 09; 131(9S):1-6.
    View in: PubMed
    Score: 0.366
  31. Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes. Am J Respir Crit Care Med. 2018 02 15; 197(4):463-469.
    View in: PubMed
    Score: 0.360
  32. Reply to Voelkel: Cigarette Smoke Is an Endothelial Cell Toxin. Am J Respir Crit Care Med. 2018 01 15; 197(2):274-275.
    View in: PubMed
    Score: 0.358
  33. Chronic Obstructive Pulmonary Disease: Breathing New Life into Old Cardiovascular Drugs? Ann Am Thorac Soc. 2017 11; 14(11):1718.
    View in: PubMed
    Score: 0.352
  34. A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 06 01; 195(11):1464-1476.
    View in: PubMed
    Score: 0.342
  35. B cells in chronic obstructive pulmonary disease: moving to center stage. Am J Physiol Lung Cell Mol Physiol. 2016 Oct 01; 311(4):L687-L695.
    View in: PubMed
    Score: 0.324
  36. B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015 Sep 15; 192(6):695-705.
    View in: PubMed
    Score: 0.304
  37. A novel nonhuman primate model of cigarette smoke-induced airway disease. Am J Pathol. 2015 Mar; 185(3):741-55.
    View in: PubMed
    Score: 0.289
  38. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med. 2010 Oct 15; 182(8):1011-9.
    View in: PubMed
    Score: 0.212
  39. Sexual intercourse and respiratory failure. Respir Med. 2008 Jun; 102(6):927-31.
    View in: PubMed
    Score: 0.181
  40. B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort. Front Immunol. 2025; 16:1508786.
    View in: PubMed
    Score: 0.148
  41. Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease. Mol Ther. 2025 Mar 05; 33(3):917-932.
    View in: PubMed
    Score: 0.145
  42. Lung Tissue Multilayer Network Analysis Uncovers the Molecular Heterogeneity of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1219-1229.
    View in: PubMed
    Score: 0.144
  43. Mice with lymphatic dysfunction develop pathogenic lung tertiary lymphoid organs that model an autoimmune emphysema phenotype of COPD. Am J Physiol Lung Cell Mol Physiol. 2025 Jan 01; 328(1):L1-L14.
    View in: PubMed
    Score: 0.143
  44. COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD. Eur Respir J. 2024 Sep; 64(3).
    View in: PubMed
    Score: 0.142
  45. Sexual activity and respiratory disease: A systematic review. Respir Med. 2024 07; 228:107665.
    View in: PubMed
    Score: 0.139
  46. TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase. Nat Commun. 2023 11 14; 14(1):7349.
    View in: PubMed
    Score: 0.134
  47. Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types? Am J Respir Cell Mol Biol. 2023 11; 69(5):500-507.
    View in: PubMed
    Score: 0.134
  48. CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice. JCI Insight. 2023 03 22; 8(6).
    View in: PubMed
    Score: 0.128
  49. Comorbidities and mortality risk in adults younger than 50?years of age with chronic obstructive pulmonary disease. Respir Res. 2022 Sep 27; 23(1):267.
    View in: PubMed
    Score: 0.124
  50. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort. Respirology. 2022 04; 27(4):286-293.
    View in: PubMed
    Score: 0.118
  51. Hedgehog interacting protein (HHIP) represses airway remodeling and metabolic reprogramming in COPD-derived airway smooth muscle cells. Sci Rep. 2021 04 27; 11(1):9074.
    View in: PubMed
    Score: 0.112
  52. Plasma metabolomics and clinical predictors of survival differences in COPD patients. Respir Res. 2019 Oct 15; 20(1):219.
    View in: PubMed
    Score: 0.101
  53. The Course of Lung Function in Middle-aged Heavy Smokers: Incidence and Time to Early Onset of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 12 01; 198(11):1449-1451.
    View in: PubMed
    Score: 0.095
  54. Beclin-1 regulates cigarette smoke-induced kidney injury in a murine model of chronic obstructive pulmonary disease. JCI Insight. 2018 09 20; 3(18).
    View in: PubMed
    Score: 0.094
  55. Supplementation with Qter? and Creatine improves functional performance in COPD patients on long term oxygen therapy. Respir Med. 2018 09; 142:86-93.
    View in: PubMed
    Score: 0.093
  56. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort. PLoS One. 2018; 13(2):e0193143.
    View in: PubMed
    Score: 0.090
  57. A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of ?-Catenin. Am J Respir Crit Care Med. 2016 07 15; 194(2):185-97.
    View in: PubMed
    Score: 0.081
  58. Simplifying the guidelines: The 10 COPD commandments. Arch Bronconeumol. 2016 Apr; 52(4):179-80.
    View in: PubMed
    Score: 0.079
  59. Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD). Expert Opin Ther Targets. 2016 Jul; 20(7):869-83.
    View in: PubMed
    Score: 0.078
  60. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med. 2016 Feb; 22(2):163-74.
    View in: PubMed
    Score: 0.078
  61. Protective role for club cell secretory protein-16 (CC16) in the development of COPD. Eur Respir J. 2015 Jun; 45(6):1544-56.
    View in: PubMed
    Score: 0.073
  62. Exercise capacity and cytochrome oxidase activity in muscle mitochondria of COPD patients. Respir Med. 2010 Jan; 104(1):83-90.
    View in: PubMed
    Score: 0.050
  63. Oxidative stress promotes lipid-laden macrophage formation via CYP1B1. Redox Biol. 2025 Feb; 79:103481.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.